PSMA targeted conjugate compounds and uses thereof
US11202836B2 · kind B2 · utility
1Cited by
56References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 23, 2020 |
| Grant date | Dec 21, 2021 |
| Priority date | — |
| Expiry date | Sep 23, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
PSMA targeted conjugate compounds, pharmaceutical compositions comprising these compounds, methods for treating and detecting cancers in a subject, methods for identifying cancer cells in a sample are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.